EMCURE logo

Emcure Pharmaceuticals L

EMCURE·NSE·
1,848.90 -6.40 (-0.34%)
Market Cap35016.59 Cr
PE Ratio37.92
Volume1,12,750
Day High - Low1885.00 - 1835.00
52W High-Low2048.00 - 1260.00
DocStoX Score
6.4/10
Fair
Fair Value
Sign in to see
ROE
20.10%
Strong
P/E
37.92x
Expensive
Debt / Equity
0.43
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day1835
1885
52W1260
2048
DocStoX take

Supported by risk (9.5) and growth (7.5), but held back by valuation (1.1). Risk looks strong at 9.5, but that is offset by valuation at 1.1. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.4
/10
Fair
Quality
Solid
ROE 20.1%
Valuation
Expensive
P/E 37.9×
Growth
Strong
Revenue +12.8% 5Y CAGR
Risk
Low risk
D/E 0.43
Momentum
Strong
75% of 52-week range

At a glance

Market Cap
₹35,017 Cr
52W High / Low
₹2048 / ₹1260
Dividend Yield
0.19%
Promoter Holding
77.83%
EPS (TTM)
₹48.76
Book Value
₹261.00

Key highlights

  • Profitable in all of the last 5 years
  • Capital works hard — ROCE 24%
  • Strong returns on equity (20%)
  • Valuation is weak (1.1/10)
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

EMCURE PHARMACEUTICALS L peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.